Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

FU-tet-o-hKLF4 Citations (4)

Originally described in: A high-efficiency system for the generation and study of human induced pluripotent stem cells.
Maherali N, Ahfeldt T, Rigamonti A, Utikal J, Cowan C, Hochedlinger K Cell Stem Cell. 2008 Sep 11. 3(3):340-5.
PubMed Journal

Articles Citing FU-tet-o-hKLF4

Articles
PAX5 is the transcriptional activator of mucolipin-2 (MCOLN2) gene. Valadez JA, Cuajungco MP. Gene. 2015 Jan 25;555(2):194-202. doi: 10.1016/j.gene.2014.11.003. Epub 2014 Nov 6. PubMed
KLF4 N-terminal variance modulates induced reprogramming to pluripotency. Kim SI, Oceguera-Yanez F, Hirohata R, Linker S, Okita K, Yamada Y, Yamamoto T, Yamanaka S, Woltjen K. Stem Cell Reports. 2015 Apr 14;4(4):727-43. doi: 10.1016/j.stemcr.2015.02.004. Epub 2015 Mar 12. PubMed

Associated Plasmids

p63 establishes epithelial enhancers at critical craniofacial development genes. Lin-Shiao E, Lan Y, Welzenbach J, Alexander KA, Zhang Z, Knapp M, Mangold E, Sammons M, Ludwig KU, Berger SL. Sci Adv. 2019 May 1;5(5):eaaw0946. doi: 10.1126/sciadv.aaw0946. eCollection 2019 May. PubMed
Disease-related p63 DBD mutations impair DNA binding by distinct mechanisms and varying degree. Osterburg C, Ferniani M, Antonini D, Frombach AS, D'Auria L, Osterburg S, Lotz R, Lohr F, Kehrloesser S, Zhou H, Missero C, Dotsch V. Cell Death Dis. 2023 Apr 18;14(4):274. doi: 10.1038/s41419-023-05796-y. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.